Lilly to begin rollout of Tempo® Personalized Diabetes Management Platform

Centralized experience supports diabetes self-management through medication reminders, education resources and insulin dose logging Data shared through...

Related Keywords

United States ,American ,Kevin Cammack ,Joe Fletcher ,Prnewswire Eli Lilly ,Kristiane Silva Bello ,Eli Lilly ,Google ,Instagram ,Linkedin ,Tempo Customer Support Service ,Twitter ,American Diabetes Association ,Lilly United States ,Garmin ,Bluetooth Sig Inc ,Facebook ,Dexcom Inc ,Apple Health ,Drug Administration On ,Health Outcomes ,Exchange Commission ,Continuous Glucose Monitoring Systems ,Tempo Blood Glucose Monitor ,Personalized Diabetes Management Platform ,Tempo Smart ,Smart Button ,Drug Administration ,Tempo Insights ,Connected Care ,Tempo Smart Button ,Tempo Pen ,Dexcom Continuous Glucose Monitoring ,European Conformity ,Tempo Personalized Diabetes Management ,Tempo Personalized Diabetes Management Platform ,Tempo Pens ,Safety Information ,Healthcare Provider ,Temposmart App ,Tempo Smart Button Instructions ,Temposmart App User Guides ,Tempo Welcome Kit ,Tempo Refill Kit ,Prescribing Information ,Private Securities Litigation Reform Act ,United States Securities ,Behavior Change ,Improve Health Outcomes ,Tempo Rings ,Silva Bello ,Lilly Media ,Lilly Investors ,Eli Lilly And Company ,